Helen is a highly experienced leader of Regulatory, Clinical and Quality. Helen previously served in leadership roles in both start-ups (TriFlo Cardiovascular and Cephea Valve Technologies, acquired by Abbott) and multinationals (Abbott and Boston Scientific) across the full product development lifecycle in the structural heart space. Helen holds a BSc. in Industrial Chemistry from the University of Limerick and started her career in Pharma prior to discovering her passion for Regulatory Affairs with roles of increasing responsibility at Boston Scientific. During this time Helen relocated to the US and is based on the west coast.
